<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[RSS Feed]]></title><description><![CDATA[RSS Feed]]></description><link>http://direct.ecency.com</link><image><url>http://direct.ecency.com/logo512.png</url><title>RSS Feed</title><link>http://direct.ecency.com</link></image><generator>RSS for Node</generator><lastBuildDate>Mon, 11 May 2026 06:22:54 GMT</lastBuildDate><atom:link href="http://direct.ecency.com/@davidwalter/rss" rel="self" type="application/rss+xml"/><item><title><![CDATA[GSK Bribery Case in China - Part 2: GSK Company Profile]]></title><description><![CDATA[This story focuses on GlaxoSmithKline (GSK), a multinational healthcare company that researches and manufactures a range of products to help people do more, feel better and live longer. GSK recognizes]]></description><link>http://direct.ecency.com/bribery/@davidwalter/gsk-s-bribery-case-in-china-part-2</link><guid isPermaLink="true">http://direct.ecency.com/bribery/@davidwalter/gsk-s-bribery-case-in-china-part-2</guid><category><![CDATA[bribery]]></category><dc:creator><![CDATA[davidwalter]]></dc:creator><pubDate>Wed, 27 Dec 2017 19:01:09 GMT</pubDate><enclosure url="https://images.ecency.com/p/3jpR3paJ37V8t3d5gG8YxUrFtTrvhgCDjjN8jFs77zjR8fThpxofZJqq9PrAqdRigovXVF7S7KEHPCspsoaSKA5YePfJNgUUhkmTvD3r8K9gbWMs3Wc2MZiMgVGbWnpQdYRPt?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[GSK Bribery Case in China - Part 1: Pharmaceutical Industry Overview: M&As, R&D and competition]]></title><description><![CDATA[The market domination of corporate pharmaceutical giants (i.e., Johnson & Johnson, Roche and Pfizer – Top 3 as of December 2017) enables them to dictate drug prices. In the past years, pharmaceutical]]></description><link>http://direct.ecency.com/pharmaceutical/@davidwalter/gsk-bribery-case-in-china-part-1-pharmaceutical-industry-overview-m-and-as-r-and-d-and-competition</link><guid isPermaLink="true">http://direct.ecency.com/pharmaceutical/@davidwalter/gsk-bribery-case-in-china-part-1-pharmaceutical-industry-overview-m-and-as-r-and-d-and-competition</guid><category><![CDATA[pharmaceutical]]></category><dc:creator><![CDATA[davidwalter]]></dc:creator><pubDate>Sun, 24 Dec 2017 19:50:54 GMT</pubDate><enclosure url="https://images.ecency.com/p/3jpR3paJ37V8t3d5gG8YxUrFtTrvhgCDjjN8jFs77zjR8fThpxofZJqq9PrAqdRigovXVF7S7KEHPCspsoaSKA5YePfJNgUUhkmTvD3r8K9gbWMs3Wc2MZiMgVGbWnpQdYRPt?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[Self-introduction: First Steemit post]]></title><description><![CDATA[Happy holidays, Steemit! David Walter here. An educator and freelance writer with background on Business and International Trade. I would be blogging on business-related topics. Rest assured that all of]]></description><link>http://direct.ecency.com/self-introduction/@davidwalter/self-introduction-first-steemit-post</link><guid isPermaLink="true">http://direct.ecency.com/self-introduction/@davidwalter/self-introduction-first-steemit-post</guid><category><![CDATA[self-introduction]]></category><dc:creator><![CDATA[davidwalter]]></dc:creator><pubDate>Sun, 24 Dec 2017 19:21:24 GMT</pubDate></item></channel></rss>